The administration of drugs and vaccines by the intranasal route.
作者信息
Freestone D S, Weinberg A L
出版信息
Br J Clin Pharmacol. 1976 Oct;3(5):827-30. doi: 10.1111/j.1365-2125.1976.tb00634.x.
Abstract
摘要
相似文献
1
The administration of drugs and vaccines by the intranasal route.通过鼻内途径给药和接种疫苗。
Br J Clin Pharmacol. 1976 Oct;3(5):827-30. doi: 10.1111/j.1365-2125.1976.tb00634.x.
2
Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?将药物和疫苗重新配方用于鼻腔给药：将最小风险转化为最大效益？
Drug Discov Today. 2011 Jan;16(1-2):4-7. doi: 10.1016/j.drudis.2010.11.001. Epub 2010 Nov 10.
3
Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.全身作用药物的鼻内给药：小分子和生物大分子
Eur J Pharm Biopharm. 2014 Sep;88(1):8-27. doi: 10.1016/j.ejpb.2014.03.004. Epub 2014 Mar 28.
4
Absorption enhancers for nasal drug delivery.用于鼻腔给药的吸收促进剂。
Clin Pharmacokinet. 2003;42(13):1107-28. doi: 10.2165/00003088-200342130-00003.
5
Oral Mucosa for Delivery of Drugs, Allergens and Vaccines: Where are we Now?
Curr Drug Deliv. 2016;13(2):172-4. doi: 10.2174/156720181302160427000605.
6
Study on the range of usefulness of a new dual form intranasal medicament.
Arch Otolaryngol (1925). 1949 Aug;50(2):190-9. doi: 10.1001/archotol.1949.00700010199004.
7
Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.使用颗粒系统进行疫苗鼻内递送的药学方面。
J Pharm Sci. 2009 Mar;98(3):812-43. doi: 10.1002/jps.21493.
8
[The transnasal route of drug administration. Aspects of nasal anatomy and physiology].
Pharm Acta Helv. 1989;64(12):322-31.
9
[Problems of drug administration in drinking water in poultry husbandry].
Dtsch Tierarztl Wochenschr. 1986 Jul 23;93(7):300-3.
10
The Impact of Breakthrough Therapy Designation on Development Strategies and Timelines for Nononcology Drugs and Vaccines.突破性治疗药物认定对非肿瘤药物和疫苗研发策略及时间线的影响。
Clin Pharmacol Ther. 2016 Dec;100(6):603-605. doi: 10.1002/cpt.447. Epub 2016 Sep 23.
引用本文的文献
1
Assessment of the nasal passages.鼻腔评估。
Br J Clin Pharmacol. 1980 Apr;9(4):317-9. doi: 10.1111/j.1365-2125.1980.tb01056.x.
2
Absolute bioavailability of nicotine applied to different nasal regions.尼古丁应用于不同鼻腔区域的绝对生物利用度。
Eur J Clin Pharmacol. 1991;41(6):585-8. doi: 10.1007/BF00314989.
本文引用的文献
1
[OBJECTIVE TRIAL OF THE MUCOSAL-SWELLING EFFECT OF XYLOMETAZOLINE].
Sven Lakartidn. 1964 Feb 5;61:378-84.
2
Viability and infectivity of microorganisms in experimental airborne infection.实验性空气传播感染中微生物的生存能力和传染性
Bacteriol Rev. 1961 Sep;25(3):182-7. doi: 10.1128/br.25.3.182-187.1961.
3
[On the treatment of rhinitis in early childhod; thermoelectric studies on nasal decongestive agents].
Schweiz Med Wochenschr. 1959 May 9;89:510-2.
4
Intranasal use of synthetic oxytocin in management of breast-feeding.鼻内使用合成催产素在母乳喂养管理中的应用
Br Med J. 1961 Mar 11;1(5227):709-11. doi: 10.1136/bmj.1.5227.709.
5
Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores.呼吸道感染研究。I. 颗粒大小对炭疽芽孢呼吸道感染的影响。
J Hyg (Lond). 1953 Sep;51(3):359-71. doi: 10.1017/s0022172400015795.
6
[Current opinion of nasal therapy from the galenic viewpoint].
Farmaco Prat. 1969 Nov;24(11):671-83.
7
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21.感冒传播的实验。II. 对感染柯萨奇病毒A21志愿者的研究
J Hyg (Lond). 1965 Sep;63(3):327-43. doi: 10.1017/s0022172400045228.
8
Trials of intranasally administered rubella vaccine.经鼻接种风疹疫苗的试验。
J Hyg (Lond). 1971 Dec;69(4):547-52. doi: 10.1017/s0022172400021811.
9
Intranasal vaccination with RA 27-3 attenuated rubella virus.
J Pediatr. 1971 Jul;79(1):55-60. doi: 10.1016/s0022-3476(71)80058-6.
10
An iatrogenic autoantibody: immunological responses to 'pituitary snuff' in patients with diabetes insipidus.一种医源性自身抗体：尿崩症患者对“垂体鼻烟”的免疫反应。
Clin Exp Immunol. 1966 Oct;1(4):377-89.
Zotero 插件